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ABSTRACT 
Electrical Bioimpedance (EBI) measurements have proven their validity in several medical 
applications like body composition analysis and detection of melanoma among others. The 
successful application of EBI technology on the field of medicine has lead the way for 
applications in the field of personal healthcare and body performance in the field of sports. 
 
Due to the widespread use of the EBI technology and rising of new EBI applications 
requiring system portability or even suitable to wear, the manufacturer Analog devices has 
introduced in the market the first integrated system dedicated to measure EBI, the impedance 
network analyzer AD5933. The availability of this EBI spectrometer device opens up new 
horizons for the integration of the measurement systems to meet the demands of new EBI 
applications and allowing the development of portable and even wearable measurement systems. 
 
This project is focused on the AD5933 impedance network analyzer, and it aims to identify 
the EBI applications in which, the use of an AD5933 device is suitable. To adapt the AD5933 
device for biomedical measurements an Analog Front-End (AFE) has been used to enable the 
system for 4-electrodes measurements. In order to evaluate the performance of AD5933 with the 
AFE, experimental measurements on electrical equivalent models have been taken with the 
AD5933+4E-AFE system and the EBI spectrometer Impedimed SFB7. The obtained impedance 
spectral data have been used to estimate the values of the equivalent circuit under measurement 
and the estimated values have been mutually compared in terms of estimation accuracy. 
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CHAPTER 1  
INTRODUCTION 
1.1 Introduction 
Nowadays there is many and several applications of Electrical Bioimpedance (EBI), these 
have been emerging as answers to clinical needs as methods for non-invasive monitoring and the 
detection of changes in the structure and composition of tissues produced by pathophysiological 
processes. 
 
A new Integrated Circuit (IC), the AD5933 is available to perform EBI measurements 
allowing for the development of small-integrated EBI measurement systems enabling portable 
and wearable systems. 
1.2. Motivation  
The increase of ageing population demands that the model of hospital centered healthcare 
turns towards one model of healthcare more personalized and home care-based. In this way, the 
patient involvement on the health care process will increase potentially increasing prevention and 
early detection what will provide eventually in a better and more affordable treatment. Such 
changes create the need to develop a new efficient, sustainable and useful technology to equip the 
patient with a tool for a personal health monitoring and simultaneously allowing the healthcare 
staff to monitor remotely the conditions of the patients. 
 
The latter together with the technological development of the field of functional textiles 
point out to the emerging area of personalized healthcare monitoring as plausible area of 
operation. EBI technology combines both the potential to be used in personalized healthcare as 
well as being able to benefit from the technological developments within functional textiles. The 
only piece missing to enable the development of wearable EBI measurement systems for 
personalized healthcare monitoring is the electronic device that will allow the implementation of 
EBI measurement systems as wearable systems. 
 
Recently the manufacturer of integrated circuits, Analog Devices, has introduced in the 
market the first integrated system dedicated to measure EBI: the AD5933. The availability of this 
EBI spectrometer device opens up new horizons for the integration of the measurement systems 
of EBI into portable and even wearable systems. To adapt the AD5933 device for human 
measurements an Analog Front-End has been developed to realize measurements with four 
electrodes wires. 
 
There are many applications that could benefit from such a small device the AD5933 and a 
natural and mandatory step in any development process is to identify which medical and 
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healthcare applications of EBI are potential candidates to benefit from the use AD5933-based 
systems. 
1.3. Goal 
The main goal of this thesis is to identify the EBI applications suitable to be implemented 
with an AD5933 enabled system. 
1.4. Work done 
As previously mentioned, this project is focused on the identification of applications of EBI 
suitable to be implemented with the set AD5933 + 4E-AFE. In order to reach the mentioned goal, 
the following work has been done: 
 
 Experimental EBI Measurements have been taken with the device SFB7 in a healthy 
subject for the following EBI applications: 
o Total Body Composition (TBC) 
o Respiration Rate (RR) 
o Lungs Composition (LC) 
o Segmental Body Composition (SBC) 
 Arm-Arm (AA) 
 Leg-Leg (LL) 
 Trunk-Trunk (TT) 
 Experimentally based electrical 2R1C models equivalent to each EBI application have 
been built. 
 The AD5933+4E-AFE has been customized by adjusting the values of internal 
components to each of the applications. 
  For comparison purposes Impedance measurements on each of the built 2R1C model 
have been performed with both the AD5933+4E-AFE device and the SFB7 Spectrometer. 
 All the obtained measurements, from both spectrometers, have been processed and a 
performance comparison has been done based on the bias error obtained on the estimation 
of the value of the original model parameters. 
1.5. Structure of the Thesis Report 
This thesis report is organized in 6 chapters and a final section for the references. Chapter 1 
contains the introduction part of this thesis report. Chapter 2 provides a brief background EBI, the 
measurement methods and the applications. Chapter 3 describes the instrumentation and the 
methods used in this thesis while Chapter 4 shows the obtained results. Finally, Chapter 5 
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discusses the results and the work done and Chapter 6 ends the report with the conclusion and 
proposal for future work. 
1.6. Out of Scope 
The following issues have not covered during this thesis work because they have been 
considerate outside the scope of the project: 
 
- To implement a new embedded system and software with the purpose to implement an 
automatic customization of the AD5933 +4F-AFE. 
 
- To test for the plausibility of EBI applications those require short time-continuous 
measurements like impedance cardiography (ICG). 
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CHAPTER 2  
BACKGROUND 
2.1. Introduction to Electrical Bioimpedance 
2.1.1. Historical Introduction 
The first reported contact with the electrical properties of biological tissue was done by Luigi 
Galvani [1], who on 1780 observed that while an assistant was touching the sciatic nerve of a frog 
with a metal scalpel, the frog‟s muscle moved when he drew electric arcs on a nearby 
electrostatic machine. 
 
After several developments in electronic instrumentation like the Volta electrochemical 
battery as the Continuous DC current source developed by Volta in 1800, the galvanometer from 
1820, high AC voltage/current pulse generators from 1831 and the continuous AC current sources 
from 1867, the detection of small bioelectrical currents became possible. 
 
It was not until 1921 that Phillippson [4] made the first tissue impedance measurement as a 
function of frequency, and found that the capacitance varied approximately as the inverse square 
root of the frequency. After that, Fricke in 1924 [5] proposed an electrical equivalent model of 
Bioimpedance for tissue and blood, here he assumed that cell are electrically represented by a 
resistance Ri, intracellular fluid and capacitance C, cell membrane, in series and a resistance Re 
representing the extracellular fluid in parallel. In 1928, 4 years before the publication of Fricke, 
Kenneth S. Cole [6] found the expressions for the impedance at DC and infinite frequency and 
paved the way for an analytical and mathematical treatment of tissue immittivity and permittivity. 
 
Therefore, the first application of bioimpedance techniques for monitoring applications 
appeared as early as 1940, impedance cardiography [7]. Since then, bioimpedance measurements 
have been used in several medical applications; examples from a long list are lung function 
monitoring [8], body composition [9] and skin cancer detection [10]. 
 
2.1.2. Electricals Properties of Biological Tissue 
The passive electrical properties, conductivity and permittivity, of biological tissue have 
their origin on the biochemical and structural composition of biological tissue. The uneven 
distribution of the body constituents and the morphological differences among cells confer to 
most of tissues with a high grade of anisotropy and inhomogeneity of their electrical properties. 
13 
 
Most often biological tissues are composed by group of cells, which are surrounded by a cell 
membrane containing the intracellular fluid inside the cell membrane, that are suspended on 
extracellular fluid. Both intracellular and extracellular fluids are rich in proteins and electrolytes, 
see Table 2.1 Such composition provides them with ionic conductivity and are often modeled, 
from an electrical point of view, as a conductance. 
 
One of the most important constituents of the cell is the plasmatic membrane, also known as 
cell membrane. The cell membrane is a layer that separates two different physiological spaces. 
The cell membrane consists of proteins and phospholipids forming a bilayer lipid membrane of 
approximately 7 nm thick. See Figure 2.1 
 
TABLE 2.1: CONCENTRATION OF ELECTROLYTES IN BODY LIQUIDS (MEQ/L) 
IS ION. CONCENTRATION IN MILLIEQUIVALENTS (MMOLE*VALENCY Z) PER LITER.
 
Note. Table extracted from [1]  
 
Figure 2.1 Lipidic Bilayer including integral and peripheral proteins forming the Cell 
Membrane  
Note that his Image has been downloaded from the University of New South Wales-Sidney. 
Available at http://cellbiology.med.unsw.edu.au/units/science/lecture0803.htm 
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Each monolayer has its hydrophobic surface oriented inward and its hydrophilic surface 
outward towards either the intra- or extracellular fluids. The intrinsic electrical conductance of 
this structure is very poor, of the order or 10
-6
S/m and it is considered as a dielectric material. An 
important property of a dielectric is its ability to support an electrostatic field and therefore 
storage energy. The total structure formed by the intracellular fluid, plasma membrane and 
extracellular fluid forms a conductor-dielectric-conductor alike structure behaving as a capacitor, 
with an approximate capacitance of 1 µF/cm
2
. 
2.1.3. The Dispersion Windows 
The passive electric properties of biological tissue present certain dependency on the 
frequency. Therefore the frequency spectrum of the electrical conductivity and permittivity is not 
constant presenting four transition regions, which are known as dispersion windows, can be 
observed. The classification of the dispersion windows is based on the electrical examination of 
biomaterials as a function of frequency that is known as dielectric spectroscopy. H.P. Schwan 
divided the relaxation mechanisms initially in 3 groups, [11] and later in 4 groups, providing the 
four identified dispersion windows. Known as α, β,  and γ-dispersions.; see Figure 2.2. 
2.2. Measurements of Electrical Bioimpedance 
2.2.1. The Cell Membrane  
The electrical properties of the tissular constituents confer a frequency dependency to the 
electrical bioimpedance and therefore any proper equivalent electrical models should represent 
such dependency. H. Fricke in 1924 [5] proposed a simple electrical equivalent model made by 
resistors and capacitors, see Figure 2.3. 
 
In Figure 2.3 a) and b) the capacitor Cm represents the membrane, Rm represents the 
resistance of the ionic channels (high value due to their low conductivity) and Re and Ri represent 
the extra cellular and intracellular fluids respectively. Fricke‟s model is depicted in Figure 2.3 c) 
 
Figure 2.2 Frequency dependence of the conductivity and permittivity of brain grey matter. Plots from [3]  
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and notice that the resistance of the membrane has been neglected due to its extremely large 
value. 
 
The impedance spectrum of a cell according to Fricke‟s model is given by the following 
equation: 
 
     (2.1) 
 
According to this simplified model, the electrical behavior at high and low frequencies can 
be explained as follows: 
 
 At low frequency, the membrane impedance is very high and only a small portion of the 
current flows through the cells and most of the current flows through the extracellular 
fluid as shown in the left side of Figure 2.4. Therefore the impedance is represented by 
only Re. 
 
 At high frequency, the capacitive effect of the plasma membrane decreases and the 
current flows through the intra and the extracellular fluid as shown in the right side of 
Figure 2.4. Thus, the value of the equivalent impedance becomes the parallel between 
resistances of the intra and the extracellular fluid, Ri||Re. 
 
Figure 2.3 Equivalent circuit of a cell where Re is the extracellular fluid Resistance, Ri the intracellular fluid 
Resistance, Rm the trans-membrane ionic channel Resistance and Cm represents the cell membrane 
Capacitance. 
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Biological tissue contains various different types of cells in several different arrangements 
and following the same approach applied by Fricke on the frequency range of the Beta-
Dispersion, explanatory and descriptive models can be obtained with circuit bridges. Figure 2.5 
presents a series circuit bridge and Figure 2.6 presents a parallel circuit bridge. 
2.2.2. Cole Model and Cole Plot 
Electrical Bioimpedance is a measurement of the ability of a material to create an opposition 
to the flow of electric current through the tissues and the impedance is denoted by Z. The 
impedance can be represented mathematically as a complex magnitude in cartesian coordinates, 
made up of two components, Resistance (R) and Reactance (X) (2.2), or in polar coordinates 
using magnitude (|Z|) and phase (θ) (2.3). 
 
     (2.2) 
 
 
Figure 2.4 Current paths in a suspension of cells at low and high frequencies. 
 
Figure 2.5 Equivalent model used for skin 
tissues 
 
Figure 2.6 Equivalent model typically used 
for suspension of cells 
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     (2.3) 
 
The electrical impedance of linear systems is ruled by Ohm‟s law, which relates voltage in 
volts and current in Amperes through an impedance in Ohms, as denoted in (2.4). 
 
      (2.4) 
Based in Ohm‟s law, a deflection method to measure electrical bioimpedance consist on 
applying electrical current or voltage on the tissue and measure the response of the tissue to the 
electrical stimulus. Like the input value over the impedance load is know and the complementary 
value is measured, it is possible to obtain the value of the impedance load with Ohm‟s law. Most 
often the electrical stimulus is applied into the tissue through electrodes and the electrical 
response is also measured with electrodes. Therefore in order to do EBI measurements there are 
several electrode configurations available and some of them they will be explained in the 
following section. 
2.2.3. Electrode configuration 
There are several electrode configurations, but in this section only two will be explained: 
The 2-Electrode and 4-Electrode configuration, which are the configuration relevant to this work. 
 
2-Electrode configuration 
 
With this configuration, depicted in Figure 2.7, both electrodes are used to inject the 
electrical stimulus and to measure the response produced by the tissue. Therefore, in this 
configuration the electrode-electrolyte interface impedances are in series with the sample 
impedance providing a total measured voltage VMEAS containing the sum of the voltages caused 
by the three impedances, see (2.5).  
 
   (2.5) 
 
Fig 2.7 Two electrodes configuration. 
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Therefore the impedance obtained by applying Ohm‟s law is the combination of the tissue 
impedance together with the electrode impedance. Unfortunately, these impedances can be 
difficult or almost impossible to separate and alternative measurement method must be used: The 
4-Electrode configuration. 
 
4-Electrode configuration 
 
In this method the electrical stimulus is applied with a pair of electrodes and the resulting 
response is measured with a different pair of electrodes, see Figure 2.8. Focusing on a current 
driven system, the voltage on the current injecting electrodes is not contained in the voltage 
response sensed by the system, therefore the influence of the electrodes impedance can be 
reduced (2.6). 
 
 
    (2.6) 
2.3. Applications of Bioimpedance 
To analyze EBI data for each of the applications that have been studied in this work, several 
approaches are available. In this section several methods used to obtain Body Composition 
parameters as well as the applications of Respiration Rate and Lungs Composition will be 
introduced.  
2.3.1. Body Composition 
The measurement of body fluid volumes, see Figure 2.7, Extra Cellular Water (ECW), Intra 
Cellular Water (ICW) and their sum, total body water (TBW) is important in many pathologies. 
TBW is strongly related to Fat-Free-Mass (FFM) which contains, in healthy individuals, an 
average of 73.2% of water [12]. 
 
Figure 2.8 Four electrodes configuration for a current driven system 
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Similarly, Body Cell Mass (BCM), which is an important nutritional parameter, is also 
closely connected to ICW. Independent measurements of FFM and TBW permit to detect 
dehydration, which is frequent in elderly persons or athletes after heavy training. Conversely, an 
overhydratation may indicate the presence of edema in cardiac patients of lymphoedema after a 
mastectomy. The measurement of TBW is also useful for evaluation of diuretic therapy. Renal 
patients treated by hemodialysis accumulate fluid between treatments. It is important to evaluate 
their amount of excess fluid, in order to determine how much fluid they should lose by ultra 
filtration and also how this fluid loss is distributed between ECW and ICW. Measurements of 
BCM are also important for assessing the morbidity of patients infected by HIV [13]. 
For Body Composition analysis there are several EBI methods available and two of them; BIA 
Analysis and BIVA will be introduced in the following sections. 
2.3.1.1. BIA Analysis  
Bioimpedance analysis (BIA) is a very well widespread method for assessment of Body 
Composition. It consists in the measurement of the impedance or opposition to the flow of an 
electric current through the body fluids contained mainly in the lean and fat tissue. Impedance is 
low in lean tissue, where intracellular fluid and electrolytes are primarily contained, but high in 
fat tissue. Impedance is thus proportional to TBW value. Due to the impedance in lean tissue, 
where intracellular fluid and electrolytes are primarily contained, is lower than in fat tissue and 
because of the measured body resistance differs depending on the amount of body fluids, it is 
 
Figure 2.7 Schematic of fat-free mass, total body water, 
intracellular water, extracellular water and body cell mass. 
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possible to estimate the body composition. The basic model of this method is depicted in Figure 
2.8 and it is based on the assumption that the body is a cylindrical-shape ionic conductor. In such 
volume conductor, the impedance between faces of a cylinder of finite length L and a cross 
sectional area A, when a uniform current density is applied parallel to its axis, is given by (2.7) 
 
      (2.7) 
The measured impedance is a function of both the tissue complex resistivity ρ and also the 
shape of the conductor. Although the body is not a uniform cylinder and its 
conductivity/resistivity is not constant, a relationship between the volume of body water (V) and 
the ratio length (L) to impedance can be established as in equations (2.8) and (2.9) [14]. 
 
      (2.8) 
 
       (2.9) 
 
It is easier to measure height than the conductive length, which is usually from wrist to 
ankle. Therefore, the empirical relationship denoted as in the equation 2.10. 
 
     (2.10) 
 
Due to the inherent inhomogeneity of the human body, and that (2.9) holds true for a 
homogeneous cylinder, the coefficient K in (2.10) describes an equivalent cylinder, which must 
be adjusted to match the real geometry. The value of the coefficient depends on various factors. 
More information can be obtained reading [15]. 
 
  
 
Figure 2.8 Principles of BIA from physical characteristics to body composition. Cylinder model for the 
relationship between impedance and geometry. 
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With the aim to obtain the body composition parameters the follow BIA methods are 
currently used: 
 
 Single Frequency-BIA 
 Multi Frequency-BIA 
 Spectroscopy-BIA 
 Segmental-BIA 
2.3.1.2. Single Frequency BIA 
Single Frequency Bioimpedance Analysis (SF-BIA) methods rely only on the whole-body 
impedance (Z50) or the resistance (R50) measured at 50 KHz between the wrist and the ankle, as 
shown in Figure 2.9. Impedance data are subsequently entered into predictive equations derived 
through statistical regression in order to determine TBW, from which FFM is calculated 
according to the assumption that FFM is hydrated at 73.2% [16]. 
 
Several studies showed that a frequency of 50 kHz is too low for full penetration of current 
through the cell [17]. Theoretically, these devices are unable to discriminate between ECW and 
ICW. Therefore, the use of these new devices is not recommended in cases of abnormal fluid 
distribution. i.e. pathological cases. 
2.3.1.3. Multi frequency BIA 
As with SF-BIA, Multi Frequency Bioimpedance Analysis MF-BIA uses empirical linear 
regression models but includes measurement of impedance at multiple frequencies. MF-BIA uses 
impedance data measured at least 2 frequencies: 1 at a very low frequency, usually 5 kHz, and 1 
at a high frequency, typically 50, 100, 200, or 500 kHz, to evaluate FFM, TBW, ICW and ECW 
[18]. At the lowest frequency, measurements of impedance can be used to determine ECW. At 
 
Figure 2.9 Standard placements of electrodes for wrist to ankle 4E-measurements for SF-BIA and MF-BIA 
applications. 
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higher frequencies, the current can pass through the cell membrane, and thus, the impedance 
measurements can be used to determine TBW. The impedance data are applied to regression-
derived equations in order to predict TBW, ECW, and ICW. According to [19] MFBIA is more 
accurate and less biased than SF-BIA for the prediction of ECW, whereas SF-BIA, compared to 
MF-BIA, is more accurate and less biased for TBW in critically ill subjects. [20]. 
2.3.1.4. Spectroscopy BIA 
Spectroscopy Bioimpedance Analysis operates on impedance data measured over a wide 
spectrum of frequencies, usually from 5 to 1000 kHz. To analyze the BIS-derived impedance 
data, the most practical approach for clinical applications is to perform biophysical modeling on 
the impedance data; the modeling procedure involves fitting the spectral data to the Cole model 
using nonlinear curve fitting [21] [13]. This procedure generates the Cole model parameters, as 
well as R0, R ,  and exponent α. Cole model terms are then applied to equations derived from 
the Hanai mixture theory [22], which is essentially based on the notion that the body is a 
conducting medium of water, electrolytes, and lean tissue, in addition to non-conducting material 
within it. ECW and ICW are thus calculated individually; TBW is calculated as the sum of ECW 
and ICW. 
 
Bioimpedance Spectroscopy Analysis provides a more direct, individualized measurement of 
ECW and ICW than other bioimpedance approaches. This is due, in large part, to the fact that it 
measures impedance over a broad spectrum of frequencies, rather than being limited to only 1 or 
2 frequencies, like in the case of SF-BIA and MF-BIA, respectively. Of particular importance, 
BIS differs from SF-BIA and MF-BIA in that it does not rely on statistically derived regression 
equations to predict body water volumes. Furthermore, it relies far less on assumptions that may 
be violated in disease states. For example, 2 assumptions underlying the SF-BIA method that may 
not hold true in many clinical populations are that FFM is 73% hydrated and that ICW and ECW 
are normally distributed. 
2.3.1.5. Segmental BIA 
Segmental Bioimpedance Analysis, the body is considered to comprise five interconnecting 
conducting cylinders, two legs, two arms, and the trunk, as shown in Figure 2.10. 
 
Although the trunk of the body represents as much as 50% of whole body mass, it only 
contributes around 10% to whole body impedance. This implies three aspects for body 
composition analysis when using the whole body-one cylinder- BIA approach: 
 
- Changes of the impedance are closely related to changes of the FFM of the limbs. 
- Changes of the FFM of the trunk are probably not adequately described by whole body 
impedance measurements 
- Even large changes in the fluid volume within the abdominal cavity have only minor 
influence on the measurement of FFM or BCM. 
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2.3.1.6. BIVA Analysis 
In Piccoli et al (1994) the RXc-graph method was proposed. Resistance, R and reactance, Xc 
are obtained with right-side configuration in SFBIA at 50 kHz after standardization by height H. 
In contrast to other bioimpedance methods this approach does not yield any absolute estimate of 
ECW, ICW or TBW, makes no assumptions about body geometry, hydration state, or the 
electrical model of cell membranes and is unaffected by regression adjustments. 
 
In BIVA, Z can be considered as a bivariate random vector: resistance R and reactance Xc. 
These two variables, standardized for height, are plotted as point vectors in the R–Xc plane. An 
individual vector can then be compared with the reference 50%, 75%, and 95% tolerance ellipses 
calculated in the healthy population of the same gender and race. That is called R–Xc graph 
method; see Figure 2.10. The ellipse varies with age and body size. For more information see [15] 
  
 
Figure 2.10 Five-Cylinder model of the body and the impedance for 
each segment: right arm, right leg, left arm, left leg, and trunk. 
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2.3.2. Respiration Rate (Impedance Pneumography) 
Impedance pneumography is a non-invasive technique for monitoring the respiration rate 
and involves measuring changes in the electrical impedance of the thoracic cavity. The resistivity 
of lung tissue increases due to the thinning of the alveolar walls as well as by the deformation of 
the epithelial cells and blood vessels through the expansion of the alveoli [23]. These changes in 
resistivity combined with diaphragm movements and changes in the chest circumference affect 
the overall impedance of the thoracic cavity during breathing [24]. Even though there exists a 
good correlation between the volume of inspired air and impedance of the thoracic cavity as 
pointed in [25] the volume of air in the lungs is not the responsible for the change in resistance. 
 
Figure 2.11 BIVA Pattern (RXc-graph) [2]. 
 
Figure 2.12 Electrode configurations for pneumography impedance measurements. In a) and in b) are 
respectively showed the bi-polar and the tetra-polar configuration. 
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These impedance changes are measured by injecting a low-amplitude, single high-frequency, 
constant current using a pair of „drive‟ electrodes and recording the resultant voltage changes 
either from the same pair of electrodes as in a 2-Electrode (bi-polar) configuration in the Figure 
2.12.a or from a different pair of „receive‟ electrodes placed at an appropriate location as in a 4-
Electrode (tetra-polar) configuration in the Figure 2.12.b [26]. 
 
Impedance pneumography is well tolerated by patients because it does not involve placing 
any device within the airway that may cause discomfort to the patient. Therefore, it is the most 
widely used technique for the purpose of long-term monitoring and home monitoring. 
2.3.3. Lungs Composition (Impedance Plethysmography) 
The impedance plethysmography is a non-invasive technique used to detect the changes of 
the thoracic impedance. It is known that changes of the thoracic impedance correlate with 
changes of the clinical syndromes of a lung edema due to the accumulation of fluid in the lungs 
[27] [28], see Figure 2.13. Furthermore, the thoracic impedance decreases considerably before the 
first clinical syndromes appear. So lung edema can be well detected using impedance 
plethysmography during their appearance and disappearance. 
The electrode placement for measurements of lung edema is under investigation, but there 
are two methods commonly used. The first method is the tetra polar configuration, as the Figure 
2.14.a shows and the other method uses 6 electrodes in the specific placement as shows the 
Figure 2.14.b. 
 
Figure 2.13 The figure illustrates in the left hand normal lungs and in the right hand lungs with Pulmonary 
Edema. The light blue color on the right side drawing represents water. 
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Figure 2.14 Thoracic bioimpedance measured in the tetra polar configuration in a) and the with six 
electrodes configuration in b). 
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CHAPTER 3  
INSTRUMENTATION AND METHOD 
3.1. Instrumentation 
In this section the instrumentation and materials needed to realize this thesis work will be 
introduced. In order to perform the spectroscopy EBI measurements obtained in this work, two 
impedance meters have been used: The SFB7 spectrometer manufactured by Impedimed and the 
custom made spectrometer based on the evaluation board for the Impedance Converter Network 
Analyzer AD5933 plus a 4-Electrode enabling- Analog Frond End [29]. 
3.1.1. SFB7 Body Composition Analyzer 
The Imp SFB7, shown in Figure 3.7, accurately measures current, voltage and phase angle to 
calculate the complex Electrical Bioimpedance, both resistance and reactance in a wide frequency 
range. The impedance meter utilizes Cole modeling with Hanai mixture theory for body 
composition assessment for determining the following Body Composition parameters from 
impedance data: 
 
 Total body water (TBW) 
 Extracellular fluid (ECF) 
 Intracellular fluid (ICF) 
 
The device has 3 modes of operation but only one mode has been used for the realization of 
this work: The MFBIA mode. This mode is mainly use for Bioimpedance Spectroscopy, 
 
Figure 3.1 The Imp SFB7 is a 4-Electrode EBI spectrometer and back connection for the 4E-Electrodes 
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measuring complex bioimpedance over a frequency range of 3.084 - 1024 kHz by sweeping 
through 256 frequency measurement points. The screen of the Imp SFB7 displays the measured 
data in the form of a Cole plot, a resistance vs. frequency and a reactance vs. frequency plots, see 
Figure 3.2. In addition the characteristic frequency and the Cole parameters are estimated for 
each measurement as well as the aforementioned Body Composition Analysis parameters. 
 
In any of the operation modes, several EBI measurements can be performed well 
continuously or at selected intervals of time, storing over 1000 records on the internal memory of 
the device. 
 
For more information about the operation modes the reader is referred to the User‟s manual 
of the Imp SFB7. 
 
3.1.2. The BioImp Software 
The Impedimed BioImp software application analyses and displays multi-frequency data 
measured with the Impedimed Imp SFB7 device. Figure 3.3 contains a screen-shot of the 
software. It can also be configured to read and analyze ASCII text files of multi-frequency 
impedance data from other sources. 
 
The application presents the impedance data to the user as charts showing resistance and 
reactance plotted against frequency and also a Cole plot. Note that the software indicates that the 
 
Figure 3.2 Screenshots of a MFBIA measurement with the Imp SFB7 device. The figure shows in a) the 
Measure Mode, in b) the BCA results data, in c) Impedance Cole plot and in d) resistance vs. frequency and 
reactance vs. frequency. 
29 
 
impedance plot is a Cole-Cole Plot but that is wrong, since the plot is in the impedance plot and 
the Cole-Cole plot do not represents impedance data. The data analysis fits a Cole model curve to 
the measured data, and derives body composition estimates from the Cole model. There are 
adjustable input parameters for the fitting algorithm. The source data and analysis results can be 
viewed in text form and in graphical form. 
3.1.3. Evaluation Board for the Impedance Converter Network Analyzer AD5933 
The main component of the evaluation board in Figure 3.6 is the IC manufactured by Analog 
Devices: the AD5933, see functional block on Figure 3.4. The AD5933 is a 12-bit precision 
impedance converter which combines an onboard frequency generator with a 1 MSPS Analog-to-
Digital Converter (ADC) and a Digital Signal Processor (DSP) engine which performs the 
impedance estimation. The AD5933 operates from a 2.7 V to 5.5 V power supply. The evaluation 
Board has the option to power up the entire circuitry from the USB port of the computer and it 
has an accurately trimmed 16 MHz crystal to act as a system clock to the AD5933 as well, if it is 
required. 
 
The AD5933 includes a serial I2C port as communication interface that allows the adjusting 
of several operational parameters as well as the transmission with an external Host of the 
impedance data results. In order to make the interface between the I2C signals from the AD5933 
with USB the board has a USB microcontroller that produces de I2C-USB conversion, see Figure 
3.5. 
 
 
Figure 3.3 The Impedimed BioImp applications displaying whole body bioimpedance data 
from the Impedimed Imp SFB7 device. 
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The AD5933 circuit allows the user to perform a frequency sweep with a user defined start 
frequency, frequency resolution, and number of points in the measurement sweep. In addition, the 
device allows the user to program the peak-to-peak value of the sinusoidal output signal as an 
excitation to the external unknown impedance under test connected between the VOUT and VIN 
terminals. The excitation signal for the transmission stage is provided on-chip using Direct 
Digital Synthesizer (DDS) techniques, which permit subhertz resolution. The AD5933 offers a 
frequency resolution programmable by the user down to 0.1 Hz. As a response to the voltage 
excitation, a corresponding electrical current flows through the load. This current will be sensed 
at the receiver stage and the ratio between its value and the value of the excitation voltage will be 
used to estimate the impedance value. The clock for the DDS is generated from either an external 
reference clock which is provided by the user at MCLK or by the internal oscillator. 
 
 
Figure 3.5 The block diagram of diagram block of the AD5933 evaluation board 
 
Figure 3.4 The functional block diagram of the IC AD5933 
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For detailed information about the evaluation board for AD5933, please read the datasheets 
of the AD5933 and the AD5933 evaluation board. 
3.1.4. Four Electrodes Analog Front End 
Since the AD5933 is a 2-Electrode measurements system and its electrical stimulation does 
not comply with the safety regulations, the evaluation board is connected to an Analog Front-End 
(AFE) circuit [29]. The functionality of this AFE is twofold: 
 
- To ensure that the safety conditions regarding current injection for performing EBI 
measurements in human patients are fulfilled. Basically this means that the electrical 
signals are below any safety threshold and no DC current is introduced in the body. 
 
- To adapt the AD5933 operation from a 2-Electrode measurement system to a 4-Electrode 
measurement system. This way the polarization impedance of the electrodes is removed 
from the EBI measurement and the system can be used in applications of spectral 
characterization. The AFE is connected to the evaluation board through two cables and to 
the patient through 4 electrodes. 
In short, we could consider the AFE, see Figure 3.7, as a combination of two Voltage-to- 
Current converters (V2CC), one in the direction from the AD5933 and another from the TUS to 
the AD5933. 
 
 
Figure 3.6 The evaluation board manufactured by Analog Devices. 
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Since the AD5933 applies voltage and expects a current at its input RFB, the AFE 
interfacing with the AD5933 has a voltage input and a current output. Source output expressly 
generates a current resulting from the ratio from Vout and the impedance of the Tissue Under 
Study (TUS), which is the exactly the current expected by the AD5933 at the input RFB as 
indicated in Figure 3.7. At the TUS side, the AFE has a current source as output, exciting the 
TUS with 350 μA-rms, while the input is a differential voltage measurement channel. 
 
In essence the AFE operation can be describe as follows: after the removal of the DC bias 
component from the voltage output of the AD5933 with a low pass filter at the input of the first 
V2CC, the AC voltage from Vout drives the Voltage Controlled Current Source (VCCS) 
injecting an AC current Iout in the TUS directly proportional to Vout. 
 
The second V2CC senses at its differential input the voltage drop caused at the TUS by the 
AC current generated by the first V2CC flowing through the TUS. Finally an AC current 
proportional to the voltage drop in the TUS is generated at the output of the second V2CC with 
an added DC component equivalent to the DCbias removed originally from the Vout. The total 
gain introduced by the cascade combination of both V2CC in the AFE is selectable by the 
choosing of several resistors. 
3.2. Method 
In order to evaluate the performance of the Impedance Spectrometer On-chip AD5933 +4-
Electrode Analog Frond End (4E-AFE), Impedance spectroscopy measurements for several EBI 
applications have been taken. Experimental measurements on electrical equivalent models have 
been taken with the AD5933+4E-AFE system and the EBI spectrometer Impedimed SFB7. The 
obtained impedance spectral data have been used to estimate the values of the equivalent circuit 
under measurement and the estimated values have been mutually compared in terms of estimation 
accuracy. 
 
 
Figure 3.7 Functional block diagram of the Analog Front-End. 
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The measurements have been taken on 2R1C equivalent models [30], each of them 
representing an specific EBI application. The electrical equivalence has been established both in 
terms of frequency as well as Ohmic load dynamic range. The values of the passive electrical 
components models were obtained experimentally from experimental EBI measurements. Since 
the value of the working load depends on the EBI applications, the functioning of the 
AD5933+4E-AFE was adjusted specifically to the impedance values range of each model. Figure 
3.8 shows the work flow that has been applied in this work. 
3.2.1. Application Equivalent Modeling 
The equivalent circuit topology chosen to model the EBI applications has been the 2R1C 
[30]. To obtain the values of the passive components for each specific equivalent model, the 
following steps have taken: 
 
1. Experimental Measurements. In this step EBI measurements have been taken in a 
healthy subject for the following EBI applications:  
 
- Total Body Water contents 
- Lungs Composition 
- Respiration Rate 
- Segmental measurements for Body Composition: 
Arm-Arm, Leg-Leg, Trunk-Trunk. 
 
The specific morphological data of the subject is shown in Table 3.1. 
The 4-Electrode EBI measurements were taken with the SFB7 spectrometer within 
the frequency range 3 kHz to 1 MHz. 
 
 
Figure 3.9 Modeling process overview 
Experimental Measurements with 
SFB7 
•Lungs
•RR
•TBC
•SBC
BIOIMP Circuit Modelling
•Averaging of 100 spectroscopy 
measurements for each 
application.
TABLE 3.1 
Sex Age (years) Length(cm) Weight(Kg) 
Male 24 173 79 
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2. BioImp 2R1C-paralell bridge Circuit Modeling. The obtained spectral impedance 
data from each of the EBI application specific measurements were processed with 
the BioImp software to obtain the values for the passive components of the 
equivalent circuit model.  
 
The obtained values and parameters obtained from each EBI applications are the 
following: 
 
- 2R1C model components: 
o Intracellular Resistance (Ri) 
o Extracellular Resistance (Re) 
o Membrane Capacitor (Cm) 
- Resistance at 0 Hz ( ) 
- Resistance at  Hz( ) 
- Characteristic Frequency (Fc) 
 
The final value for each of the parameters was obtained from the averaging of 100 
spectroscopy measurements using the batch processing tool available at BioImp. 
3.2.2 EBI Application Equivalent Load 
Once typical values for the components of the 2R1C have been calculated by averaging the 
experimentally performed EBI measurements, a typical dynamic range for the resistance was 
obtained. The maximum value of the model is set by Re and the minimum is set by the parallel 
connection of Re//Ri.  
 
Since the circuit parameters have been obtained from a single subject and both Re and Ri 
have an strong dependency on the size and the form of the tissue under study i.e. the whole body. 
The values of the resistors of the 2R1C bridge have been adjusted considering for the variance in 
morphological parameters of the population i.e. size, complexion, high etc. The applied process is 
explained as follows in the next diagram, see Figure 3.10. 
1. Increasing the Load Dynamic Range. The range of values of the load was 
increased not directly over the 2R1C model but on the Cole parameters. Since the 
EBI spectrometer measures bioimpedance down to 0 Ohms, the upper limit of the 
range was adjusted modifying the value of R0. The new R0‟ value was obtained by 
 
Figure 3.10 EBI Application Equivalent Load and Customization Process Overview 
Increasing Load Dynamic Range
•RE=R0'=R0(1+α)
AD5933+4E-AFE application customization
•RG1, R4 and RRFB
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using a multiplicative factor (1+α) for R0, where  is a constant set to 0.5. i.e. the 
value of R0 was increased 50%, see Equation 3.1. 
 
    (3.1) 
 
Due to this modification the values of the equivalent 2R1C model for the 
resistances Ri and Re and Cm were recalculated aiming to keep the original 
frequency dependency. The value recalculation was done as follows. The 2R1C 
circuit was simplified for D.C: 
According to the previous figure Re‟ is equal to R0‟, that is the maximum value of 
the resistance that the EBI spectrometer will measure for a given EBI application 
and therefore the AD5933, will be adjusted for a RTUS max equal to the newly 
obtained Re‟ to make the best use of the ADC. See Equation 3.2. 
 
     (3.2) 
 
In order to keep the value of the characteristic frequency of the 2R1C similar to the 
typical value of each corresponding EBI application, the value of Ri was 
recalculated keeping the obtained value of Re‟ and the original value of Cm as 
follows in Equation 3.3. 
 
    (3.3) 
 
The calculated values were used to build the equivalent electrical model 2R-1C for 
each application. Each model was implemented with a resistor as Re, a capacitor as 
Cm and a potentiometer for Ri with the purpose to tune the value to keep original 
Fc of the EBI application. 
 
2 AD5933+4E-AFE application customization: Once the values for each of the 
models have been obtained, the AD5933+4E-AFE was customized by adjusting 
the values of the following resistors: Rrfb, R4 and applying (3.4) and (3.5). 
 
Figure 3.11 2R1C parallel Bridge for f=0 
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From the AC Analysis: 
 
  (3.4) 
 
From the DC Analysis: 
 
   (3.5) 
 
In order to make the most of the dynamic range of the ADC of the sensing stage of 
the AD5933, a DC bias voltage was introduced at the input with the value. Solving 
(3.6) for it was found that the values for Rrfb and R4 and must be equal. 
 
   (3.6) 
 
    (3.7) 
 
     (3.8) 
 
     (3.9) 
 
By means of the AC analysis, an amplitude voltage at the input of the sensing stage 
of 1.5 Volts was applied and the resistance RG1, the gain resistance of INA111 on 
the 4E-AFE, was calculated with the Equation 3.10: 
 
   (3.10) 
 
From the analysis, it was obtained that several parameters have common values for 
all the EBI applications. The Table 3.2 lists the parameters with the corresponding 
values common for the EBI applications: 
 
TABLE 3.2 
Rcc1 Resistor of the voltage-current converter amplifier  7.5KΩ 
R4 Resistor current-voltage 10 KΩ 
Rrfb Feedback resistor 10 KΩ 
Vi Vac injection 1.98V 
Vdd Vdc supply 3V 
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This way RG1 is the only parameter left that must be adjusted specifically to each 
application. Table 3.3 lists each of the obtained values for RG1 for each EBI 
application. 
3.2.3 EBI Application Equivalent Spectroscopy Measurements  
Hence, with the optimization of the system AD5933+4E-AFE already done, the impedance 
measurements for each model were made with both devices: the SFB7 and the AD5933+4E-AFE. 
3.2.3.1. SFB7 measurements. 
100 spectroscopy measurements have been taken in the frequency range from 
3kHz to 1MHz for each of the equivalent circuits. Each obtained spectrum was 
saved in a text file, which contains the measurement frequency and both the 
measured resistance and reactance. The SFB7 distributes the measurement 
frequencies, exponentially distributing 256 measurement points between 3 kHz to 
1 MHz. See Figure 3.12. This frequency distribution dedicates more measurement 
points to lower frequencies than for higher frequencies. 
TABLE 3.3 
APPLICATION RG1(Ω) 
TBC 6619 
Arm-Arm 2851 
Leg-Leg 3858 
Trunk-Trunk 801 
LC 654 
RR 481 
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3.2.3.2 AD5933+4-AFE measurements. 
100 spectroscopy measurements have been taken in the frequency range from 
3kHz to 100KHz. Each obtained spectrum was saved in a CSV file, which 
contains the measured frequencies, impedance, phase, resistance and reactance. 
AD5933 distributes the measurement frequencies lineally distribution 501 
measurements points between 3kHz and 100KHz. See Figure 3.13. This frequency 
distribution dedicates the same number of point to high and low frequencies 
because the sample points are equidistant.  
 
 
Figure 3.12 Frequency distribution of SFB7 
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Figure 3.13 Frequency distribution of AD4933+4-AFE 
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All the obtained measurements, from both spectrometers, were processed with BioImp 
Software. In order to process the measurements taken by the AD5933+4E-AFE, a Matlab script 
was done in MATLAB to prepare the data files generated by the software controlling the 
AD5933+4E-AFE [31] to be imported by BioImp Software. In addition to the file conversion a 
specific file type definition was declared in BioImp to read the files as shown in Figure 3.14. 
3.2.4 Performance Comparison 
The performance comparison was done based on the error obtained from the model 
parameters estimation, which was done from the impedance measurements from both systems, 
according to the work flow diagram showed in the Figure 3.15. 
 
 
 
Figure 3.14 File definition Impedimed 
 
Fig 3.15 Performance comparison Process Overview 
 
Model Parameter 
Estimation 
•BioImp batch 
processing
Statistical Error 
Analysis
•MS Excel
•Average
•Standard deviation
•Maximum and 
Minimum  
•Absolute and 
Relative Error
Estimation Error 
Visualization 
•Matlab Plot
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3.2.4.1 Model Parameter Estimation. 
Once the files containing the 2R1C-models impedance measurements were 
uploaded into BioImp, the data files were batch processed to estimate the 2R1C 
parameters, see Figure 3.16. The estimation results from each measurement were 
saved into MS Excel format, see Figure 3.17. This way for each EBI application 
model two files containing the estimated parameters were obtained from the 
measurements taken with the SFB7 and the AD5933+4-AFE spectrometer. 
 
 
 
Figure 3.16 Batch results of Ri, Re and Cm 
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3.2.4.2 Statistics of the Model Parameter Estimation. 
Each of the exported files from BioImp was processed with MS Excel to obtain the 
following statistical parameters from the values of Re, Ri, Cm and Fc: 
 
o Average 
o Standard deviation 
o Maximum and Minimum   
o Absolute and Relative Error 
 
Note that the errors have been calculated comparing the estimated values with the 
real value of the passive components used to build the 2R1C. 
 
3.2.4.3 Estimation Error Visualization.  
To obtaine the plots with the comaprison results, the statistical values have been 
exported to a workspace of MatLab. Once in Matlab the average, maximum, 
minimum of the estimated values and the value of the component of each EBI 
model application have been plotted. 
 
  
 
Figure 3.17 Data output file export options of BioImp 
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CHAPTER 4  
RESULTS 
4.1 Overview 
This chapter presents the results obtained from the measurements and the data analysis 
performed as described in the previous chapter. Firstly, the EBI spectroscopy measurements for 
each EBI application obtained with the SFB7 spectrometer will be shown by means of resistance 
and reactance spectra. Secondly, the values of the equivalent 2R1C models estimated from the 
initial obtained EBI spectroscopy measurements and the values of the implemented model will be 
listed in terms of Re, Ri and Cm. Thirdly, the Impedance spectroscopy measurements taken from 
the implemented 2R1C-equivalent models with, both the SFB7 and AD5933+4-AFE, will be 
displayed represented as in the first point and finally, the comparison of both bioimpedance 
spectroscopy (BIS) devices will be shown with different statistical graphs. 
4.2 SFB7 Measurements  
In order to obtain an electrical circuit equivalent to the EBI measurement scenarios under 
study in this thesis work, experimental EBI Spectroscopy measurements have been taken and 
they are shown in the following graphs. The spectrum of the resistance and the reactance for each 
EBI scenario are plotted between in the frequency range 3 kHz to 1 MHz. 
4.2.1 Total Body Composition (TBC): 
In Figure 4.1 a) it is possible to observe that the maximum and minimum values of the resistance 
are approximately 600 Ω and 418 Ω respectively providing us with a dynamic range of 
approximately 182 Ω. 
 
Figure 4.1 The spectra of the resistance and reactance are plotted respectively in a) and b). In b) it is 
possible to observe that there is only one dominant dispersion with a Fc value approximately of 28 kHz 
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4.2.2 Respiration Rate (RR): 
 
In Figure 4.2 a) it is possible to observe that the maximum and minimum values of the 
resistance are approximately 37 Ω and 21 Ω respectively providing us with a dynamic range of 
approximately 16 Ω. 
4.2.3 Lungs Composition (LC): 
 
In Figure 4.3 a) it is possible to observe that the maximum and minimum values of the 
resistance are approximately 50 Ω and 29 Ω respectively providing us with a dynamic range of 
approximately 21 Ω. 
 
Figure 4.2 the spectra of the resistance and reactance are plotted respectively in a) and b). In b) it is possible 
to observe that there is only one dominant dispersion with a Fc value approximately of 24 kHz 
 
Figure 4.3 the spectra of the resistance and reactance are plotted respectively in a) and b). In b) it is possible 
to observe that there is only one dominant dispersion with a Fc value approximately of 21 kHz 
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4.2.4 Segmental Body Composition (SBC): 
4.2.4.1 Arm-Arm (AA) 
 
The effect observed at high frequencies, especially in the reactance, is consistent with the 
commonly known as Hook effect, which usually strongly affects measurements at frequencies 
above 500 kHz [32]. 
 
Despite the observed Hook Effect present in the EBI measurements, in Figure 4.4 b) it is 
possible to observe that the maximum and minimum values of the resistance are approximately 
238 Ω and 170 Ω respectively providing us with a dynamic range of approximately 68 Ω. 
4.2.4.2 Trunk-Trunk (TT): 
Once again the hook effect can be observed at high frequencies in Figure 4.5, especially in 
the reactance in Figure 4.5 b). Nevertheless, in the spectrum of the resistance in Figure 4.5 a), it is 
possible to observe that the maximum and minimum values of the resistance are approximately 
60 Ω and 38 Ω respectively providing us with a dynamic range of approximately 22 Ω. 
  
 
Figure 4.4 the spectra of the resistance and reactance are plotted respectively in a) and b). In b) besides to 
present a dispersion with a Fc value approximately of 34 kHz, it shows a second dominant dispersion at High 
frequencies. 
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4.2.4.3 Leg-Leg (LL): 
In Figure 4.6 a) it is possible to observe that the maximum and minimum values of the 
resistance are approximately 328 Ω and 223 Ω respectively providing us with a dynamic range of 
approximately 105 Ω. 
 
Figure 4.6 the spectra of the resistance and reactance are plotted respectively in a) and b). In b) it is possible 
to observe that there is only one dominant dispersion with a Fc value approximately of 28 kHz 
 
Figure 4.5 the spectra of the resistance and reactance are plotted respectively in a) and b). In b) besides 
to present a dispersion with a Fc value approximately of 21 kHz, it shows a second dominant dispersion 
at high frequencies. 
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4.2.1. Measurements Summary 
The obtained spectroscopy EBI measurements present a resistance and a reactance with a 
strong frequency dependency. The dynamic range of impedance values for both resistance and 
reactance is listed below. 
 
4.3 Modeling 2R1C 
After processing all the EBI measurements obtained for each application with the batch 
processing tool of the BioImp software and averaging the results, the values for the parameters of 
the 2R1C-equivalent circuit model and the characteristic frequency for each application have 
been obtained. The values are listed in Table 4.2  
 
 
The load dynamic range has been enlarged to increase the applicability of the working 
models to more subjects. Therefore the components of the 2R1C-equivalent circuit have been re-
calculated according to the process previously explained in section 3.2 and the newly obtained 
theoretical values are listed in the Table 4.3: 
TABLE 4.1 REACTANCE AND RESISTANCE RANGE PER APPLICATION 
Applications Rmax Rmin Xcmax Xcmin 
TBC 600 412 68.81 11.98 
RR 40.54 20.1 6.87 -2.6 
LC 54.18 25.3 8.85 -2.95 
AA 241.2 168.4 26.91 10.81 
TT 61.46 36.53 9.73 4.7 
LL 333.89 222.35 42.99 -25.85 
 
TABLE 4.2. RE, RI, CM AND FC PER APPLICATION 
Applications Re(Ω) Ri(Ω) Cm(nF) Fc(KHz) 
TBC 622 1149.5 2.99 30.1 
RR 39.6 41.5 77.1 25.5 
LC 54 50.5 46.2 33.0 
AA 246.5 477.9 6.37 34.5 
TT 66.4 67.1 46.5 25.6 
LL 340.8 633.9 6.61 25.3 
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The circuit was implemented using an E-24 series resistor for Re, a potentiometer for Ri and 
a MKT370 (Vishay BC) series capacitor for Cm. The values for the circuit components were 
adjusted to the experimental values of Re and Cm trimming the potentiometer Ri, this way 
obtaining the final values for the 2R1C components. See Table 4.4. 
 
 
  
TABLE 4.3 THEORETICAL VALUES OF THE 2R1C COMPONENTS 
Application Re(Ω) Cm(nF) Fc(KHz) Ri(Ω) 
TBC  933 2.99 30.1 835 
RR 59.4 77.1 25.5 21.5 
LC 81 46.2 33 23.4 
AA 369.75 6.37 34.5 354 
TT 99.6 46.5 25.6 34 
LL 511.2 6.61 25.3 440 
 
TABLE 4.4 FINAL VALUES OF THE 2R1C COMPONENTS 
Application Re(Ω) Cm(nF) Fc(KHz) Ri(Ω) 
TBC  917.5 3.42 30.1 629 
RR 58.5 75.7 25.5 23.9 
LC 81.5 47.7 33 19.6 
AA 364.6 6.20 34.5 379 
TT  99 44 25.6 42.3 
LL 510 6.55 25.3 450 
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4.4. Spectroscopy Measurements in 2R1C Models 
Once the equivalents electrical circuits and the optimization of AD5933+4E-AFE have been 
already done, the impedance measurements for each model were made by both, the device SFB7 
and the AD5933+4E-AFE. The obtained measurements with each of the spectrometers for each 
application are shown in the follow figures. 
4.4.1 TBC: 
Figure 4.7 contains the plots of the reactance and resistance spectrum of the TBC application 
obtained from the SFB7 and AD5993+4-AFE. In the resistance spectrum it is possible to observe 
that the maximum and minimum values are approximately 900 Ω and 390 Ω respectively, 
providing us with a dynamic range of approximately 510 Ω. As the graphs denote the curves, 
resistance and reactance for both devices are overlapped, which means that the measurements of 
SFB7 and AD5933+4-AFE are very similar. It is also possible to observe that at low frequencies, 
between 3kHz and 6KHz, the device AD5933+4-AFE produce certain dispersion on the 
measurement. 
  
 
Figure 4.7 the left part of the figure the spectra resistance and the right part the spectra reactance are 
plotted measured from, SFB7 and AD5993+4-AFE. In the reactance is possible to observe that there is 
only one dominant dispersion with a Fc value approximately of 30 kHz 
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4.4.2 RR: 
In Figure 4.8 the reactance and resistance spectra of the TBC application for SFB7 and 
AD5993+4-AFE are plotted. In the resistance curve is possible to observe that the maximum and 
minimum values are approximately 57 Ω and 16 Ω respectively, providing us with a dynamic 
range of approximately 41 Ω. As the graphs denote the curves, resistance and reactance for the 
both devices are overlapped, therefore it means that the measurements of SFB7 and AD5933+4-
AFE are very similar. It is also possible to observe that at low frequencies, between 3kHz and 
6KHz, the measurements performed with the device AD5933+4-AFE present a dispersion. 
4.4.3 LC: 
In Figure 4.9 the reactance and resistance spectra of the TBC application for SFB7 and 
AD5993+4-AFE are plotted. In the resistance curve is possible to observe that the maximum and 
minimum values are approximately 80 Ω and 18 Ω respectively, providing us with a dynamic 
range of approximately 62 Ω. As the graphs denote the curves, resistance and reactance for the 
both devices are overlapped, therefore it means that the measurements of SFB7 and AD5933+4-
AFE are very similar. It is also possible to observe that at low frequencies, between 3KHz and 
6KHz, the measurements performed with the device AD5933+4-AFE present a dispersion. 
 
 
Figure 4.8 the left part of the figure the spectra resistance and the right part the spectra reactance are 
plotted measured from both, SFB7 and AD5993+4-AFE. In the reactance is possible to observe that there 
is only one dominant dispersion with a Fc value approximately of 27 kHz 
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4.4.4 AA: 
 
In the Figure 4.10 is plotted the reactance and resistance of the TBC application for SFB7 
and AD5993+4-AFE. 
 
 
Figure 4.9 the left part of the figure the spectra resistance and the right part the spectra reactance are 
plotted measured from both, SFB7 and AD5993+4-AFE. In the reactance is possible to observe that 
there is only one dominant dispersion with a Fc value approximately of 35 kHz 
 
Figure 4.10 the left part of the figure the spectra resistance and the right part the spectra reactance are 
plotted measured from both, SFB7 and AD5993+4-AFE. In the reactance is possible to observe that 
there is only one dominant dispersion with a Fc value approximately of 35 kHz 
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In the resistance curve is possible to observe that the maximum and minimum values are 
approximately 365 Ω and 185 Ω respectively, providing us with a dynamic range of 
approximately 180 Ω. As the graphs denote the curves, resistance and reactance for the both 
devices are overlapped; therefore it means that the measurements of SFB7 and AD5933+4-AFE 
are very similar. It is also possible to observe that at low frequencies, between 3kHz and 6KHz, 
the measurements performed with the device AD5933+4-AFE present a dispersion. 
4.4.5 LL: 
In the Figure 4.11 is plotted the reactance and resistance of the TBC application for SFB7 
and AD5993+4-AFE. In the resistance curve is possible to observe that the maximum and 
minimum values are approximately 500 Ω and 240 Ω respectively, providing us with a dynamic 
range of approximately 260 Ω. As the graphs denote the curves, resistance and reactance for the 
both devices are overlapped; therefore it means that the measurements of SFB7 and AD5933+4-
AFE are very similar. It is also possible to observe that at low frequencies, between 3KHz and 
6KHz, the measurements performed with the device AD5933+4-AFE present a dispersion. 
4.4.6 TT: 
In the Figure 4.12 is plotted the reactance and resistance of the TBC application for SFB7 
and AD5993+4-AFE. 
 
 
Figure 4.11 the left part of the figure the spectra resistance and the right part the spectra reactance are 
plotted measured from both, SFB7 and AD5993+4-AFE. In the reactance is possible to observe that there 
is only one dominant dispersion with a Fc value approximately of 25 kHz 
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In the resistance curve is possible to observe that the maximum and minimum values are 
approximately 98 Ω and 31 Ω respectively, providing us with a dynamic range of approximately 
67 Ω. As the graphs denote the curves, resistance and reactance for the both devices are 
overlapped, therefore it means that the measurements of SFB7 and AD5933+4-AFE are very 
similar. It is also possible to observe that at low frequencies, between 3kHz and 6kHz, the 
measurements performed with the device AD5933+4-AFE present a dispersion. 
4.4.7 Comparison among the Theoretical Model Values and the Estimated Model Values 
With one of the measurements taken by each device, SFB7 and AD5933 +4- AFE, and once 
the data were processed with BioImp software to obtain the value of Re, Ri, Cm and Fc then 
Figure 4.13 has been produced. It shows the comparison between the estimated model values Re, 
Ri, Cm and the characteristic frequency Fc obtained for each application and device with the 
theoretical measured values, which are enlisted in Table 4.5. 
 
 
TABLE 4.5 THEORETICAL VALUES 2R1C COMPONENTS 
Application Re(Ω) Ri(Ω) Cm(nF) Fc(kHz) 
TBC 933 835 2.99 30.1 
RR 59.4 21.5 77.1 25.5 
LC 81 23.4 46.2 33 
AA 369.75 354 6.37 34.5 
TT 99.6 34 46.5 25.6 
LL 511.2 440 6.61 25.3 
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In Figure 4.13 it is possible to observe the calculated value and the obtained value from the 
measurements of both devices are quite similar, the maximum difference is in the value of Ri, 
between the calculated value and obtained value from the devices in the TBC application. 
4.5. SFB7 Vs. AD5933+4-AFE 
In order to show the performance comparison between the SFB7 and the AD5933+4-AFE 
the following statistical parameters were chosen: 
 
- Absolute and Relative Error 
- Average 
- Standard deviation 
- Maximum and Minimum   
 
Figure 4.13 This graph shows in a) the membrane capacitance, in b) the intracellular resistance, in c) the 
extracellular Resistance and in d) the characteristic frequency per each application and measured with, 
both devices the SFB7 and AD5933+4-AFE, and also the theoretical value calculated. 
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Therefore, with all the measurements already processed with BioImp software, all the 
estimation results were exported to a MS Excel file. Once all the data were exported to MS Excel, 
the statistical values were calculated with the statistical tools available within MS Excel. Firstly, 
the absolute and relative error comparisons between SFB7 and AD5933+4-AFE were done. 
Figure 4.14 and 4.15 show both errors. 
 
 
Figure 4.14 Relative error of Ri, Re, Cm and Fc for each application and device: SFB7 and AD5933+4-AFE. 
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As it is possible to see in Figure 4.14 in all the calculated values for each application the 
relative error produced by the AD5933+4-AFE is slightly bigger than the produced by the SFB7. 
The maximum relative error with regarding to the real value of each parameter is about of 8% and 
it occurs in the TT application, also the average value of the relative error is approximately 
around 2%. 
 
The absolute error per application and circuital value of the used model is shown in Figure 
4.15 and it was shown in the case of the relative error but in the respective units that the error 
obtained with the AD5933+4-AFE is larger than the error obtained with the SFB7. The maximum 
absolute error in the case of the calculated value from the impedance measurements is for the 
resistors about 10 Ω, for the capacitor about 4pF and for Fc is 2kHz 
 
Secondly, the standard deviation was calculated also with MS Excel. Figure 4.16 shows the 
comparison of the standard deviation obtained with each of the devices. 
 
 
 
Fig 4.15 Absolute error of Ri, Re, Cm and Fc per each application and device (SFB7 and AD5933+4-AFE) 
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Although the relative error obtained with the AD5933+4-AFE is most of the time larger 
than the error obtained with the SFB7, as shown in Figure 4.15, the standard deviation of the 
SFB7 is larger than the standard deviation produced by the AD5933+4-AFE in all the circuital 
values calculated in each of the applications. 
 
Finally in Matlab, the average, maximum, minimum of the estimated values and the real 
value of the component of each EBI model application have been plotted on Figures 4.17, 4.18, 
4.19, 4.20, 4.21 and 4.22. 
  
 
Figure 4.16 Standard deviation of Ri, Re, Cm for each application and impedance spectrometer device: 
SFB7 and AD5933+4-AFE. 
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Figure 4.17 the maximum, minimum, average and real values of the 2R1C model (Re, Ri and Cm) and 
the characteristic frequency (Fc) for the segmental body composition Arm-Arm application. 
 
Figure 4.18 the maximum, minimum, average and real values of the 2R1C model (Re, Ri and Cm) and 
the characteristic frequency (Fc) for the Respiration Rate application. 
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Figure 4.19 the maximum, minimum, average and real values of the 2R1C model (Re, Ri and Cm) and the 
characteristic frequency (Fc) for the segmental body composition Leg-Leg Application. 
 
Figure 4.20 the maximum, minimum, average and real values of the 2R1C model (Re, Ri and Cm) and the 
characteristic frequency (Fc) for the Lungs Composition application. 
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Figure 4.21 the maximum, minimum, average and real values of the 2R1C model (Re, Ri and Cm) and the 
characteristic frequency (Fc) for the Total Body Composition application. 
 
Figure 4.22 the maximum, minimum, average and real values of the 2R1C model (Re, Ri and Cm) and the 
characteristic frequency (Fc) for the segmental body composition Trunk-Trunk application. 
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The previous figures show the maximum, minimum, average and real values for the 2R1C 
model and it is possible to see that in almost in all the EBI applications, the SFB7 produces a 
closer value to the real values of the of the 2R1C models than the values estimated with the 
AD5933+4-AFE measurements, as shown in Figure 4.14 and Figure 4.15, the relative error and 
the absolute error respectively. In addition the Figures show with the indicators of the maximums 
and minimums that the dispersion of estimations produced by the SFB7 measurements is larger 
than the estimations produced with the AD5933+4-AFE measurements as shown in Figure 4.16. 
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CHAPTER 5  
DISCUSSION 
5.1. Performance of 2R1C Components Estimation 
Although experimental EBI measurements were used to obtain the values of the components 
of the 2R1C models. The values of the bridge resistors were adjusted with α parameter in order to 
consider the variance in the morphology of the population like size, weight, complexion etc. 
Nevertheless the α parameter was chosen arbitrarily modifying all the models. Therefore, in order 
to improve this step of the parameters estimation a target study should be realized in several 
subjects to reach a better approximation to an α parameter in an empiric way. 
5.2. Study of Errors: Relative Error and Standard Deviation 
Table 5.1 and Table 5.2 show respectively the relative error and the standard deviation of the 
devices SFB7 and AD5933. Therefore according to the theoretic definition of accuracy and 
precision and with the dates from tables, it is possible to affirm that the device SFB7 has a better 
accuracy than AD5933 due to its low relative error with real values and the AD5933 has a better 
preciseness than SFB7 because of the exhibited low standard deviation.  
“The accuracy is the degree of closeness of a measured or calculated quantity to its actual 
true value” [33], while Precision or Preciseness the quality of being reproducible in amount or 
performance. 
TABLE 5.2 STANDARD DEVIATION: SFB7 VS. AD5933+4-AFE 
SFB7/AD5933 Ri Cm Re Fc 
AA 3.06E-01 1.33E-01 1.88E-03 9.57E-04 4.71E-02 2.35E-02 7.56E-03 5.15E-03 
RR 4.93E-02 2.38E-02 4.44E-02 1.81E-02 1.77E-02 7.70E-03 1.79E-02 8.54E-03 
LL 3.57E-01 2.21E-01 2.66E-03 1.92E-03 9.77E-02 5.55E-02 7.80E-03 3.27E-03 
LC 4.98E-02 1.93E-02 1.49E-02 1.17E-02 1.93E-02 1.31E-02 1.54E-02 8.76E-03 
TBC 5.54E-01 1.28E-01 9.15E-04 3.05E-04 1.59E-01 4.23E-02 5.32E-03 2.17E-03 
TT 7.99E-02 2.17E-02 2.03E-02 8.11E-03 3.04E-02 1.22E-02 1.26E-02 5.25E-03 
 
TABLE 5.1 RELATIVE ERROR: SFB7 VS. AD5933+4-AFE 
SFB7/AD5933 Ri Cm Re Fc 
AA 0.01% 1.36% 1.47% 1.65% 0.06% 0.31% 1.52% 1.11% 
RR 0.08% 1.63% 1.50% 2.14% 0.29% 1.03% 1.70% 2.42% 
LL 0.20% 1.20% 0.78% 0.94% 0.14% 0.19% 0.80% 0.48% 
LC 0.44% 3.63% 2.16% 2.97% 0.16% 0.53% 2.24% 2.68% 
TBC 0.14% 1.64% 2.22% 1.47% 0.04% 0.36% 2.31% 1.01% 
TT 0.04% 2.13% 7.19% 8.25% 0.11% 0.36% 7.82% 8.54% 
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Given the large amount of obtained data and according to Table 5.1, Table 5.3 was made as 
summary of the worst case of error per application and device. It has made adding the square of 
the relative error obtained for every circuit parameter per each EBI application. 
 
Taking into account Table 5.3, the device SFB7 has exhibited a lower error in the estimation 
of the circuit parameters of model 2R1C in almost all the EBI application, except in the 
application Total Body Composition, in which the AD5933+4-AFE has a 0.76% less of error than 
the SFB7. The higher difference between both devices is in the Lungs Composition application, 
with 2.28% and the highest error in both systems are in the application Trunk-Trunk. 
 
In order to decide for which applications the AD5933+4-AFE is more suitable to use, we 
have focused in error in medical applications attending to the following expression: 
 
Measurement Error < Estimator Error < Application Error 
 
On one hand, in the measurement of lungs circulate air volume [34] [35] the error measured 
with a neumotacometer and with EIT is around 20%, then the application error is almost two 
times higher (12%) than the worse EBI application error studied in this work. On the other hand, 
in peritoneal dialysis [36] using the impedance parameter R normalized by body height H for the 
right-side (RRS/H) versus mean blood pressure (BPMEAN), the standard deviation for unstable and 
stable patients is 4.90 ± 2.87 and 8.19 ± 2.26, respectively. Consequently the data are spread out 
over the average with maximums errors around 58% and 28%, respectively. 
 
Therefore is possible to affirm that the AD5933 is perfectly suitable for all the applications 
that this work has studied. 
5.3. Spectral Results 
The spectral comparison between SFB7 and AD5933+4-AFE per application, showed in 
section 4.4, present a dispersion at low frequency, between 3 kHz and 6 kHz. This effect could be 
because the system had not reached the steady state at these frequencies or because at these low 
frequencies the system is not able to reject the secondary harmonics of the main harmonic. Those 
problems could be solved just by adding a delay at low frequencies for once or adding a filter in 
the AFE in the other case. 
 
TABLE 5.3 QUADRATIC ADDITION 
Application SFB7  
AA 2.11% 2.43% 
RR 2.29% 3.76% 
LL 1.14% 1.61% 
LC 3.15% 5.43% 
TBC 3.21% 2.45% 
TT 10.62% 12.07% 
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As it was possible to see on the spectral plots for each application the continuous blue line 
representing the measurements obtained with the AD5933+4-AFE follow accurately the 
discontinuous red line representing the measurements taken with the SFB7, in both resistance and 
reactance. Whereupon the spectroscopy measurements performance exhibited by the AD5933+4-
AFE it is possible to conclude that the device will be suitable for the applications under study. 
 
  
64 
 
CHAPTER 6  
CONCLUSIONS & FUTURE WORK 
6.1. Conclusions 
After all the results shown in the chapter 4 and discussion in chapter 5, it can be concluded 
that the combination AD5933+4-AFE is suitable to realize spectroscopy measurements of the 
EBI applications studied in this master thesis. This result has significant repercussions as in 
economic terms due to the high integration of AD5933 (I2C interface, DDS, Amplifiers, PGA, 
Low pass Filter, ADC, DSP and Temperature sensor) as in the electronic instrumentation because 
it opens up new horizons for the integration of the measurement systems of EBI into portable and 
even wearable systems. 
6.2. Future work 
Once the main target of this work has been done, with the aim to solve some problems or to 
improve the applied method and the system AD5933+4-AFE the next points has brought up: 
 
 The α parameter was chosen arbitrarily and due to it all the models have been 
affected. Therefore, in order to improve this step in the estimation a study in several 
subjects should be realized to reach better approximation to α parameter by empiric 
way. 
 The frequency distribution of measurements performed by the SFB7 and AD5933+4-
AFE is exponential and linear, respectively. With the goal of improving the 
comparison between both devices, it will be better to change by software the 
frequency distribution of the AD5933. 
 To use resistors and capacitors with a low tolerance, in order to obtain a lower 
variability between the models measurements  
 To add a larger delay at low frequencies or adding a filter in the AFE to reduce de 
dispersion at low frequencies. 
 Due to the spectral variability of the impedance under study in each application and 
to make suitable the combination AD5933+4-AFE for many applications, it will be a 
good improvement to add a differential PGA (Programmable Gain Amplifier) or 
scalable resistors array. 
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